KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Neogenomics (NEO) over the last 17 years, with Q3 2025 value amounting to -$27.1 million.

  • Neogenomics' Net Income towards Common Stockholders fell 5327.98% to -$27.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$113.5 million, marking a year-over-year decrease of 4598.09%. This contributed to the annual value of -$78.7 million for FY2024, which is 1050.61% up from last year.
  • As of Q3 2025, Neogenomics' Net Income towards Common Stockholders stood at -$27.1 million, which was down 5327.98% from -$45.1 million recorded in Q2 2025.
  • In the past 5 years, Neogenomics' Net Income towards Common Stockholders registered a high of $77.4 million during Q2 2021, and its lowest value of -$49.4 million during Q1 2022.
  • Its 5-year average for Net Income towards Common Stockholders is -$21.9 million, with a median of -$24.3 million in 2023.
  • Data for Neogenomics' Net Income towards Common Stockholders shows a peak YoY increase of 123459.85% (in 2021) and a maximum YoY decrease of 54898.5% (in 2021) over the last 5 years.
  • Neogenomics' Net Income towards Common Stockholders (Quarter) stood at -$41.8 million in 2021, then soared by 45.67% to -$22.7 million in 2022, then surged by 36.85% to -$14.3 million in 2023, then dropped by 6.97% to -$15.3 million in 2024, then crashed by 77.04% to -$27.1 million in 2025.
  • Its last three reported values are -$27.1 million in Q3 2025, -$45.1 million for Q2 2025, and -$25.9 million during Q1 2025.